Christian Dowdeswell

Arcinova Appoints Christian Dowdeswell as New Managing Director

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova, Quotient Sciences' CRDMO.

Siegfried Announces Changes in Senior Management Team

Siegfried has appointed Marianne Späne, currently chief business officer Drug Products, as chief business officer with responsibility for both the Drug Substances and Drug Products divisions of the Swiss contract manufacturing and development organization (CDMO), effective Feb. 1, 2024. Christian Dowdeswell, who previously led the Drug Substance business, has decided to leave Siegfried.

Experts Statements: Christian Dowdeswell, Lonza

Lonza Adds More Building Blocks for the Healthcare Continuum